Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.

Supporting cutting-edge research at colleges and universities — even, or especially, in its earliest stages, before anyone ...

Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...

Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my ...

Gates funds geoengineering experiments globally. Simply because there is no official evidence to prove weather manipulation ...

A former Pfizer Inc. scientist denied an allegation made by House Republicans that he conspired to delay the release of Covid ...

A federal court dismissed a journalist’s claims against Pfizer executives and a member of the former Biden Administration for ...

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...

BioNTech SE's turn toward oncology treatments has the potential to tap multi-billion-dollar markets in the future. Find out ...

Wall Street’s major averages ended slightly lower last week, after posting back-to-back record closes as market participants juggled Trump's tariff announcements against a healthy appetite for ...

Marc Filippino Like really big tariffs. Donald Trump voice clip If they have to bring the pharmaceuticals into the country, the drugs and other things into the country, they’re gonna be tariffed at a ...